Novartis expands health programs to 30+ countries by 2030 to improve heart disease and cancer care access.

Novartis is expanding its community health programs targeting heart disease and cancer care from 11 to over 30 countries by 2030. The initiative includes three models: Inclusive Health Accelerators in five U.S. cities focusing on cancer care access, Community Health Initiatives in low- and middle-income countries to speed diagnosis and treatment, and CARDIO4Cities, which uses real-time data to improve heart health in urban areas. These programs aim to close healthcare gaps in underserved populations by enhancing prevention, early detection, and follow-up care, building on successful pilot projects that improved treatment rates and health outcomes. This expansion addresses slowing progress in chronic disease management globally and seeks sustainable solutions for better healthcare access.